Literature DB >> 27214082

Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia.

S-E Lee1, S-A Yahng2, B-S Cho1, K-S Eom1, Y-J Kim1, H-J Kim1, C-K Min1, S Lee1, S-G Cho1, D-W Kim1, W-S Min1, J W Lee1.   

Abstract

The aim of this study was to evaluate the impact of pretransplant transfusion of packed red cells (PRCs) on outcome after allogeneic stem cell transplantation (SCT) in severe aplastic anemia (SAA). A total of 221 adult SAA patients receiving allogeneic SCT were analyzed. The patients were divided into two groups according to the amount of pretransplant transfusion before SCT: the low transfusion group (⩽32 PRC units, n=164) and the high transfusion group (>32 PRC units, n=57). The incidence of engraftment failure was not different between the two groups. The incidence of acute GvHD (grades II-IV) was higher in the high transfusion group than in the low transfusion group (P=0.04), and the incidences of chronic extensive GVHD were not significantly different (P=0.136). The high transfusion group had higher 5-year transplant-related mortality (TRM) (24.8% vs 6.8%, P<0.001) and lower overall survival (OS) (72.3% vs 91.9%, P<0.001) than those in the low transfusion group. Multivariate analysis revealed that the high transfusion group and unrelated donor type were independent prognostic factors affecting OS. These results indicate that a history of higher pretransplant transfusion of PRCs was associated with increased TRM and decreased OS, suggesting that iron overload had a negative impact on outcome after SCT in SAA.

Entities:  

Mesh:

Year:  2016        PMID: 27214082     DOI: 10.1038/bmt.2016.140

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  28 in total

Review 1.  Ferritin in serum. Clinical and biochemical implications.

Authors:  A Jacobs; M Worwood
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

2.  Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Rammurti T Kamble; George B Selby; Martha Mims; Mohamed A Kharfan-Dabaja; Howard Ozer; James N George
Journal:  Biol Blood Marrow Transplant       Date:  2006-05       Impact factor: 5.742

3.  The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia.

Authors:  Jong Wook Lee; Byung Sik Cho; Sung Eun Lee; Ki Seong Eom; Yoo Jin Kim; Hee Je Kim; Seok Lee; Chang Ki Min; Seok Goo Cho; Woo Sung Min; Chong Won Park
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-25       Impact factor: 5.742

4.  Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.

Authors:  V Pullarkat; S Blanchard; B Tegtmeier; A Dagis; K Patane; J Ito; S J Forman
Journal:  Bone Marrow Transplant       Date:  2008-09-01       Impact factor: 5.483

5.  Iron overload following bone marrow transplantation in children: MR findings.

Authors:  L Kornreich; G Horev; I Yaniv; J Stein; M Grunebaum; R Zaizov
Journal:  Pediatr Radiol       Date:  1997-11

6.  Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.

Authors:  A Altès; A F Remacha; A Sureda; R Martino; J Briones; C Canals; S Brunet; J Sierra; E Gimferrer
Journal:  Bone Marrow Transplant       Date:  2002-06       Impact factor: 5.483

7.  HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.

Authors:  B S Cho; K S Eom; Y J Kim; H J Kim; S Lee; C K Min; S G Cho; W S Min; C W Park; C C Kim; J W Lee
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

8.  Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Keisuke Kataoka; Yasuhito Nannya; Akira Hangaishi; Yoichi Imai; Shigeru Chiba; Tsuyoshi Takahashi; Mineo Kurokawa
Journal:  Biol Blood Marrow Transplant       Date:  2009-02       Impact factor: 5.742

Review 9.  Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea.

Authors:  Jong Wook Lee
Journal:  Int J Hematol       Date:  2008-07-05       Impact factor: 2.490

10.  Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children.

Authors:  J W Lee; H J Kang; E K Kim; H Kim; H Y Shin; H S Ahn
Journal:  Bone Marrow Transplant       Date:  2009-04-27       Impact factor: 5.483

View more
  2 in total

1.  Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sakura Hosoba; Edmund K Waller; Neeta Shenvi; Michael Graiser; Kirk A Easley; Zaid Al-Kadhimi; Akira Andoh; Ana G Antun; Sheliagh Barclay; Cassandra D Josephson; Jean L Koff; H Jean Khoury; Amelia A Langston; James C Zimring; John D Roback; Cynthia R Giver
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-04       Impact factor: 5.742

2.  Retrospective Comparison of Efficacy and Safety of Rabbit Anti-Thymocyte Globulin and Porcine Anti-Lymphocyte Globulin in Patients With Acquired Aplastic Anemia Undergoing Hematopoietic Stem Cell Transplantation From Matched Sibling Donors.

Authors:  Yuanfeng Zhang; Xin Chen; Lin Li; Yun Li; Li Lin; Yang Cao; Na Wang; Donglin Yang; Aiming Pang; Rongli Zhang; Qiaoling Ma; Weihua Zhai; Yi He; Jialin Wei; Erlie Jiang; MingZhe Han; Yicheng Zhang; Sizhou Feng
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.